Deprescribing in Outpatient Internal Medicine Practices
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 26
- 试验地点
- 2
- 主要终点
- Change in number of medications
研究概览
简要总结
The purpose of this study is to evaluate the impact of pharmacist-led medication reviews and deprescribing or de-escalation interventions on reducing the number of medications, falls, and hospitalizations, and improvement in quality of life in geriatric patients.
详细描述
With increasing age, key pharmacokinetic processes such as first-pass metabolism, bioavailability, drug distribution, and clearance, are affected, necessitating dose adjustments and careful medication management. Despite these risks, medication regimens in elderly patients are often left unchanged over time. Deprescribing, the intentional reduction or discontinuation of medications, has been shown to improve quality of life, reduce fall risk, minimize cognitive impairment, and decrease adverse drug interactions. In this analysis, the PharmD will perform a comprehensive medication review with the patient and collaborate with the provider and patient through shared decision making to deprescribe and/or dose reduce medication therapy where risks may outweigh benefits for the patient.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 75 Years 至 —(Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •75 years or older
- •taking 6 or more medications
排除标准
- •patients in hospice or palliative care
- •in Skilled Nursing Facility
- •receiving cancer/oncology treatment
研究组 & 干预措施
medication review - deprescribing / de-escalation may occur
Internal medicine providers and PharmDs will identify patients for whom a medication review and potential deprescribing / de-escalation intervention may be beneficial, and make recommendations to adjust therapy as appropriate.
干预措施: medication review (Behavioral)
historical controls
No contact or intervention will be made with these patients, only retrospective chart review to gather data such as number of medications, hospitalizations, and falls. Patients included in the historical control arm will be matched to the intervention group based on sex, age, and number of medications as much as possible. The goal will be to include 50 patients in both the intervention and control arms.
结局指标
主要结局
Change in number of medications
时间窗: Month 3
Change in number of medications
次要结局
- Change in Medication Appropriateness Index scores(Month 3)
- Change in Quality of life scores(Month 3)
- Number of documented falls(Month 3)
- Number of documented hospitalizations(Month 3)
- Number of documented visits to Primary Care Physician office(Month 3)
